Page last updated: 2024-10-15

7-deazaguanine

Cross-References

ID SourceID
PubMed CID135408714
CHEMBL ID41044
CHEBI ID190453
SCHEMBL ID311783
SCHEMBL ID9044197
MeSH IDM0183420

Synonyms (57)

Synonym
2-amino-3h,4h,7h-pyrrolo[2,3-d]pyrimidin-4-one
nsc62498
nsc-62498
inchi=1/c6h6n4o/c7-6-9-4-3(1-2-8-4)5(11)10-6/h1-2h,(h4,7,8,9,10,11
isothiazolo[5,4-b]pyridine, 4,6-dimethoxy-3-methyl-
7355-55-7
2-amino-3,7-dihydropyrrolo[2,3-d]pyrimidin-4-one
2-amino-3,7-dihydro-pyrrolo[2,3-d]pyrimidin-4-one
7-deazaguanine
2-amino-3,7-dihydro-4h-pyrrolo[2,3-d]pyrimidin-4-one
2-amino-7h-pyrrolo[2,3-d]pyrimidin-4-ol
FT-0657852
AKOS002281877
CHEBI:190453
bdbm50028122
A9480
2-amino-1h-pyrrolo[2,3-d]pyrimidin-4-ol;7-deazaguanine
2-amino-4-hydroxypyrrolo[2,3-d]pyrimidine
41687-92-7
A825627
2-amino-4-oxo-3,7-dihydro-pyrrolo[2,3-d]pyrimidine
gpl8t5zo3m ,
nsc 62498
unii-gpl8t5zo3m
4h-pyrrolo(2,3-d)pyrimidin-4-one, 2-amino-1,7-dihydro-
AKOS006343272
2-amino-3h-pyrrolo[2,3-d]pyrimidin-4(7h)-one
BP-13208
FT-0649133
FS-2371
PS-3941
AKOS015915052
AM1168
AB2630
2-amino-4 -hydroxy-7h-pyrrolo[2,3-d]pyrimidine
SCHEMBL311783
DTXSID30223745
SCHEMBL9044197
2-amino-7h-pyrrolo[2,3-d]pyrimidin-4-ol #
W-203677
2-amino-1h-pyrrolo[2,3-d]pyrimidin-4(7h)-one
4h-pyrrolo[2,3-d]pyrimidin-4-one, 2-amino-1,7-dihydro-
2-amino-3,7-dihydropyrrolo(2,3-d)pyrimidin-4-one
7h-pyrrolo(2,3-d)pyrimidin-4-ol, 2-amino-
AC-22553
mfcd00079103
mfcd09033259
CS-W020388
Z1198150171
BCP26868
SY013811
AMY812
2-amino-4-hydroxypyrrolo[2,3- d]pyrimidi
QY8 ,
2-azanyl-3,7-dihydropyrrolo[2,3-d]pyrimidin-4-one
EN300-225493
CHEMBL41044
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
organic molecular entityAny molecular entity that contains carbon.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Dual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)Ki1.50000.01000.41081.5000AID1812148
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (19)

Processvia Protein(s)Taxonomy
peptidyl-tyrosine phosphorylationDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
chromatin remodelingDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
regulation of transcription by RNA polymerase IIDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
protein phosphorylationDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
nervous system developmentDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
circadian rhythmDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
peptidyl-serine phosphorylationDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
peptidyl-threonine phosphorylationDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
peptidyl-tyrosine phosphorylationDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
negative regulation of microtubule polymerizationDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
positive regulation of RNA splicingDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
amyloid-beta formationDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
peptidyl-serine autophosphorylationDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
peptidyl-tyrosine autophosphorylationDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
negative regulation of DNA damage response, signal transduction by p53 class mediatorDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
protein autophosphorylationDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
negative regulation of mRNA splicing, via spliceosomeDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
negative regulation of DNA methylation-dependent heterochromatin formationDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
positive regulation of protein deacetylationDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
positive regulation of DNA-templated transcriptionDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (14)

Processvia Protein(s)Taxonomy
protein kinase activityDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
protein serine/threonine kinase activityDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
protein serine/threonine/tyrosine kinase activityDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
protein tyrosine kinase activityDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
non-membrane spanning protein tyrosine kinase activityDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
protein bindingDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
ATP bindingDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
RNA polymerase II CTD heptapeptide repeat kinase activityDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
identical protein bindingDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
tau protein bindingDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
tau-protein kinase activityDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
protein serine kinase activityDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
histone H3T45 kinase activityDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
transcription coactivator activityDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (8)

Processvia Protein(s)Taxonomy
cytoskeletonDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
nucleusDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
nucleusDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
nucleoplasmDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
cytoplasmDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
nuclear speckDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
axonDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
dendriteDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
ribonucleoprotein complexDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1812148Binding affinity to DYRK1A (unknown origin) assessed as inhibition constant by ADP hunter plus assay2021Journal of medicinal chemistry, 07-08, Volume: 64, Issue:13
Fragment-Derived Selective Inhibitors of Dual-Specificity Kinases DYRK1A and DYRK1B.
AID1812149Inhibition of PAK4 (unknown origin) at 200 uM by ADP hunter plus assay2021Journal of medicinal chemistry, 07-08, Volume: 64, Issue:13
Fragment-Derived Selective Inhibitors of Dual-Specificity Kinases DYRK1A and DYRK1B.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (68)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's16 (23.53)18.2507
2000's26 (38.24)29.6817
2010's17 (25.00)24.3611
2020's9 (13.24)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.45%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other68 (98.55%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]